At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 4:11:43 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 104,374 | 7 |
| Sales | 60,600 | 4 |
| Net Shares Purchased (Sold) | 43,774 | 11 |
| Total Insider Shares Held | 825.11k | -- |
| % Net Shares Purchased (Sold) | 5.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ESPOSITO PAMELA Director | Conversion of Exercise of derivative security at price 29.55 per share. | Direct | 73,875 | Dec 2, 2024 |
| ESPOSITO PAMELA Director | Sale at price 49.00 per share. | Direct | 122,500 | Dec 2, 2024 |
| ESPOSITO PAMELA Director | Conversion of Exercise of derivative security at price 14.18 - 29.55 per share. | Direct | 322,075 | Sep 17, 2024 |
| ESPOSITO PAMELA Director | Sale at price 47.75 - 48.75 per share. | Direct | 651,766 | Sep 17, 2024 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 10.34 per share. | Direct | 51,700 | Aug 26, 2024 |
| ALBERS JEFFREY W Director | Sale at price 49.10 per share. | Direct | 245,508 | Aug 26, 2024 |
| BAKER BROS ADVISORS L.P. Unknown | Purchase at price 46.41 per share. | Indirect | 46 | Aug 20, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 82,368 | Jul 16, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Sale at price 45.15 - 46.10 per share. | Direct | 1,803,143 | Jul 16, 2024 |
| MAINOLFI NELLO Chief Executive Officer | Conversion of Exercise of derivative security at price 5.33 per share. | Direct | 100,060 | Jul 1, 2024 |
| JACOBS BRUCE N. Chief Financial Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 52,000 | Jun 27, 2024 |
| MAINOLFI NELLO Chief Executive Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 29,979 | Jun 18, 2024 |
| HOROBIN JOANNA C Director | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 17,680 | Jun 7, 2024 |
| HOROBIN JOANNA C Director | Sale at price 32.65 - 33.11 per share. | Direct | 280,400 | Jun 7, 2024 |
| CHADWICK JEREMY G Chief Operating Officer | Sale at price 34.99 per share. | Direct | 90,105 | May 23, 2024 |
| ATLAS VENTURE FUND X, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 41.94 - 43.42 per share. | Indirect | 14,912,376 | Mar 13, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Sale at price 41.41 - 43.26 per share. | Direct | 139,967 | Mar 4, 2024 |
| JACOBS BRUCE N. Chief Financial Officer | Sale at price 41.41 - 43.26 per share. | Direct | 164,664 | Mar 4, 2024 |
| CHADWICK JEREMY G Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| CHINIARA ELLEN V Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| JACOBS BRUCE N. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 832 | Feb 27, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Sale at price 45.00 per share. | Direct | 18,000 | Feb 27, 2024 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 10.34 per share. | Direct | 51,700 | Feb 21, 2024 |
| ALBERS JEFFREY W Director | Sale at price 39.05 - 39.07 per share. | Direct | 195,258 | Feb 21, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 95,965 | Feb 9, 2024 |
| GOLLOB JARED AUGUST M.D. Officer | Sale at price 35.39 - 36.09 per share. | Direct | 1,638,071 | Feb 9, 2024 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 10.34 per share. | Direct | 103,400 | Jan 23, 2024 |
| ALBERS JEFFREY W Director | Sale at price 30.05 per share. | Direct | 300,470 | Jan 23, 2024 |
| CHINIARA ELLEN V. J.D. Officer | Sale at price 22.58 per share. | Direct | 74,416 | Jan 4, 2024 |
| CHINIARA ELLEN V Officer | Sale at price 22.58 per share. | Direct | 74,416 | Jan 4, 2024 |
| MAINOLFI NELLO Chief Executive Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 18,720 | Jan 2, 2024 |
| MAINOLFI NELLO Chief Executive Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 41,600 | Nov 3, 2023 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.64 - 14.07 per share. | Indirect | 5,301,325 | Nov 3, 2023 |
| MAINOLFI NELLO Chief Executive Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 24,960 | Aug 8, 2023 |
| JACOBS BRUCE N. Chief Financial Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 20,800 | Jun 2, 2023 |
| CHADWICK JEREMY G Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| CAUGHEY ELAINE Officer | Sale at price 30.88 - 31.40 per share. | Direct | 22,132 | Mar 2, 2023 |
| GOLLOB JARED AUGUST M.D. Officer | Sale at price 30.88 - 31.40 per share. | Direct | 40,233 | Mar 2, 2023 |
| JACOBS BRUCE N. Chief Financial Officer | Sale at price 30.88 - 31.40 per share. | Direct | 42,465 | Mar 2, 2023 |
| GOLLOB JARED AUGUST M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| JACOBS BRUCE N. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| CAUGHEY ELAINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 29.89 - 31.24 per share. | Indirect | 1,251,191 | Jan 12, 2023 |
| ATLAS VENTURE FUND X, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 29.96 - 30.29 per share. | Indirect | 3,821,739 | Jan 12, 2023 |
| CHINIARA ELLEN V Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2023 |
Related Tickers
NRIX Nurix Therapeutics, Inc.
19.83
-1.05%
NUVL Nuvalent, Inc.
84.22
-0.50%
ARVN Arvinas, Inc.
18.48
+3.65%
RLAY Relay Therapeutics, Inc.
4.1600
-2.35%
IDYA IDEAYA Biosciences, Inc.
25.61
+3.31%
FHTX Foghorn Therapeutics Inc.
5.14
+3.21%
RVMD Revolution Medicines, Inc.
44.06
+1.78%
CGEM Cullinan Therapeutics, Inc.
11.60
+5.94%
RYTM Rhythm Pharmaceuticals, Inc.
56.12
+1.15%
ACLX Arcellx, Inc.
75.54
+0.44%